technetium tc-99m sestamibi (Cardiolite) Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA MeSH PubChem

Active Ingredient History

NOW
  • Now

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

99m tc-sestamibi | 99m-tc sestamibi | 99mtc sestamibi | 99mtc-sestamibi | cardiolite | miraluma | mtc99 sestamibi | sestamibi | tc-99m-rp-30a | tc 99m sestamibi | tc-99m sestamibi | tc99m sestamibi | technetium (99m tc) sestamibi | technetium (99mtc) sestamibi | technetium tc 99m sestamibi | technetium tc-99m sestamibi | technetium tc-99m sestamibi kit | technetium tc-99 sestamibi

Organizations (24)

Research & Development (17)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (8)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (15)

Approved Indications (1)


 

Diagnostic Imaging (approved 1990)

Experimental Indications - Clinical Trial Phases 1-4 (14)


 

Breast Neoplasms (Early Phase 1)

Coronary Artery Disease (Phase 3)

Coronary Restenosis (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Kidney Neoplasms (Phase 2)

Lung Neoplasms (Phase 2)

Molecular Imaging (Phase 1)

Mucocutaneous Lymph Node Syndrome (Phase 3)

Myocardial Infarction (Phase 4)

Neoplasms (Phase 2)

Ovarian Neoplasms (Phase 2)

Thyroid Neoplasms (Phase 4)

Uterine Cervical Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 24
  • # of Trial Organizations: 17

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue